Video

Being Open About Mental Health Care During Cancer Treatment

Author(s):

To combat the stigma around mental health care for patients with lung cancer, survivor Nancy Cohen shares her own treatment story and why she feels it's important to include mental health care during cancer treatment.

Patients go through many emotions after receiving a cancer diagnosis, especially those with lung cancer who face stigma associated with the disease, such as smoking led to their diagnosis. Stigmas like this can cause mental health distress for which patients may not seek support, according to Nancy Cohen, a lung cancer survivor turned patient advocate, who uses her voice to help others with the disease.

Cohen recently served as the keynote speaker during the CURE® Patient-Focused Sessions at the New York Lung Cancers Symposium® on Nov. 9 addressing a crowd of more than 80 patients with lung cancer. She shared her story to highlight that there is more to the treatment journey than just taking medication and going for routine visits. In an interview with CURE®, her address focused on how mental health care is just as important and shouldn’t be overlooked.

Transcription:

The other thing that is important is managing the mental health aspect of it. I started working with a therapist who specializes in oncology patients. And, I think, we can talk about the stigma of lung cancer and the stigma of mental health and sort of making sure that neither of those is present because I think, you know, going through this is hard enough. And, going through it with a mental health professional is so important.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Dr. Masey Ross explains how biomarker testing, patient history, and quality-of-life concerns guide treatment decisions in metastatic breast cancer.
Dr. Paolo Tarantino shares how antibody-drug conjugates deliver more targeted chemo, and how the treatment lasts longer in the body vs traditional therapy.
Image of women with text.
The inMIND trial led to the FDA approval of Monjuvi with Revlimid and Rituxan for relapsed follicular lymphoma, showing benefits across diverse patients.
Clinical Trial Evaluating Monjuvi in Lymphoma Gives Lasting Responses
Survivors can find strength after cancer by focusing on goals, loved ones, and spiritual connection, especially during challenging or uncertain times.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Related Content